The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Highlighted STAT3 as a potential drug target for cancer therapy
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is a cytoplasmic transcription factor that regulates cell proliferation, differentiation, apoptosis, angiogenesis, inflammation and immune responses. Aberrant STAT3 activation triggers tumor progression through oncogenic gene expression in numerous human cancers, leading to promote tumor malignancy. On the contrary, STAT3 activation in immune cells cause elevation of immunosuppressive factors. Accumulating evidence suggests that the tumor microenvironment closely interacts with the STAT3 signaling pathway. So, targeting STAT3 may improve tumor progression, and anti-cancer immune response. In this review, we summarized the role of STAT3 in cancer and the tumor microenvironment, and present inhibitors of STAT3 signaling cascades. [BMB Reports 2019; 52(7): 415-423].
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
T cell exclusion, immune privilege, and the tumor microenvironment
Joyce, J. A., & Fearon, D. T. (2015) · Science · doi:10.1126/science.aaa6204 · Cited by 2,473
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
The role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201
NF-κB and STAT3 – key players in liver inflammation and cancer
He, G., & Karin, M. (2011) · Cell Research · doi:10.1038/cr.2010.183 · Cited by 1,197
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Self-citationInterleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O'Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 775
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633
Constitutive activation of STAT 3 in breast cancer cells: A review
Banerjee, K., & Resat, H. (2016) · International Journal of Cancer · doi:10.1002/ijc.29923 · Cited by 611
Stat3 mediates myeloid cell–dependent tumor angiogenesis in mice
Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., & Yu, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35213 · Cited by 581
Self-citationImpact of the physical microenvironment on tumor progression and metastasis
Spill, F., Reynolds, D. S., Kamm, R. D., & Zaman, M. H. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.007 · Cited by 581
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 576
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K. M., Firpo, M. A., Mulvihill, S. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 521
Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., & Takeda, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4657 · Cited by 519
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Huynh, J., Chand, A., Gough, D., & Ernst, M. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0090-8 · Cited by 504
Stem-Like Cells in Bone Sarcomas: Implications for Tumorigenesis
Gibbs, C. P., Kukekov, V. G., Reith, J. D., Tchigrinova, O., Suslov, O. N., Scott, E. W., Ghivizzani, S. C., Ignatova, T. N., & Steindler, D. A. (2005) · Neoplasia · doi:10.1593/neo.05394 · Cited by 492
Turkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Haura, E. B., Turkson, J., & Jove, R. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0195 · Cited by 430
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3099fje · Cited by 425
Self-citationSTAT3 as a central mediator of neoplastic cellular transformation
Frank, D. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.017 · Cited by 364
Strategies and Approaches of Targeting STAT3 for Cancer Treatment
Furtek, S. L., Backos, D. S., Matheson, C. J., & Reigan, P. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00945 · Cited by 347
Shin, D.-S., Kim, H.-N., Shin, K. D., Yoon, Y. J., Kim, S.-J., Han, D. C., & Kwon, B.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2575 · Cited by 309
Xiong, H., Hong, J., Du, W., Lin, Y.-W., Ren, L.-L., Wang, Y.-C., Su, W.-Y., Wang, J.-L., Cui, Y., Wang, Z.-H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 307
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells
Lin, L., Liu, A., Peng, Z., Lin, H.-J., Li, P.-K., Li, C., & Lin, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4660 · Cited by 297
Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function
Cheng, G. Z., Zhang, W., Sun, M., Wang, Q., Coppola, D., Mansour, M., Xu, L., Costanzo, C., Cheng, J. Q., & Wang, L.-H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707429200 · Cited by 285
Pardanani, A., Hood, J., Lasho, T., Levine, R. L., Martin, M. B., Noronha, G., Finke, C., Mak, C. C., Mesa, R., Zhu, H., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404750 · Cited by 272
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2
Zhao, D., Pan, C., Sun, J., Gilbert, C., Drews-Elger, K., Azzam, D. J., Picon-Ruiz, M., Kim, M., Ullmer, W., El-Ashry, D., et al. (2015) · Oncogene · doi:10.1038/onc.2014.257 · Cited by 267
Redell, M. S., Ruiz, M. J., Alonzo, T. A., Gerbing, R. B., & Tweardy, D. J. (2011) · Blood · doi:10.1182/blood-2010-04-280123 · Cited by 257
Samavati, L., Rastogi, R., Du, W., Hüttemann, M., Fite, A., & Franchi, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.018 · Cited by 256
Dechow, T. N., Pedranzini, L., Leitch, A., Leslie, K., Gerald, W. L., Linkov, I., & Bromberg, J. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404100101 · Cited by 254
Activated Signal Transducer and Activator of Transcription (STAT) 3
Silver, D. L., Naora, H., Liu, J., Cheng, W., & Montell, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3959 · Cited by 252
Targeting JAK kinase in solid tumors: emerging opportunities and challenges
Buchert, M., Burns, C. J., & Ernst, M. (2016) · Oncogene · doi:10.1038/onc.2015.150 · Cited by 243
Zhang, X., Hu, F., Li, G., Li, G., Yang, X., Liu, L., Zhang, R., Zhang, B., & Feng, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0176-3 · Cited by 243
Alas, S., & Bonavida, B. (2003) · PubMed · Cited by 240
Hossain, A., Gumin, J., Gao, F., Figueroa, J., Shinojima, N., Takezaki, T., Priebe, W., Villarreal, D., Kang, S.-G., Joyce, C., et al. (2015) · Stem Cells · doi:10.1002/stem.2053 · Cited by 224
Gao, H., Priebe, W., Glod, J., & Banerjee, D. (2009) · Stem Cells · doi:10.1002/stem.23 · Cited by 202
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 202
STAT3 and epithelial–mesenchymal transitions in carcinomas
Wendt, M. K., Balanis, N., Carlin, C. R., & Schiemann, W. P. (2014) · JAK-STAT · doi:10.4161/jkst.28975 · Cited by 200
Role of Stat3 in suppressing anti-tumor immunity
Kortylewski, M., & Yu, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.010 · Cited by 196
The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations
Geiger, J. L., Grandis, J. R., & Bauman, J. E. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.022 · Cited by 193
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Siddiquee, K. A. Z., Gunning, P. T., Glenn, M., Katt, W. P., Zhang, S., Schroeck, C., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 187
Won, C., Kim, B., Yi, E. H., Choi, K., Kim, E., Jeong, J., Lee, J., Jang, J., Yoon, J., Jeong, W., et al. (2015) · Hepatology · doi:10.1002/hep.27968 · Cited by 187
Self-citationThakur, R., Trivedi, R., Rastogi, N., Singh, M., & Mishra, D. P. (2015) · Scientific Reports · doi:10.1038/srep10194 · Cited by 183
Schaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Itoh, M., Murata, T., Suzuki, T., Shindoh, M., Nakajima, K., Imai, K., & Yoshida, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209149 · Cited by 166
Chen, J., Wang, J., Lin, L., He, L., Wu, Y., Zhang, L., Yi, Z., Chen, Y., Pang, X., & Liu, M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0648 · Cited by 164
The function of Stat3 in tumor cells and their microenvironment
Groner, B., Lucks, P., & Borghouts, C. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.005 · Cited by 162
Current status of SRC inhibitors in solid tumor malignancies
Puls, L. N., Eadens, M., & Messersmith, W. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0408 · Cited by 158
Therapeutic Targeting of the JAK / STAT Pathway
Aittomäki, S., & Pesu, M. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12164 · Cited by 152
Zhang, X., Sun, Y., Pireddu, R., Yang, H., Urlam, M. K., Lawrence, H. R., Guida, W. C., Lawrence, N. J., & Sebti, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3175 · Cited by 149
Scuto, A., Krejčı́, P., Popplewell, L. L., Wu, J., wang, Y., Kujawski, M., Kowolik, C. M., Xin, H., Chen, L., Wang, Y., et al. (2010) · Leukemia · doi:10.1038/leu.2010.289 · Cited by 140
Saudemont, A., Jouy, N., Hétuin, D., & Quesnel, B. (2004) · Blood · doi:10.1182/blood-2004-09-3458 · Cited by 139
Herrmann, A., Kortylewski, M., Kujawski, M., Zhang, C., Reckamp, K. L., Armstrong, B., Wang, L. Q., Kowolik, C. M., Deng, J., Figlin, R. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0736 · Cited by 138
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 133
Ferrajoli, A., Faderl, S. H., Van, Q., Koch, P. E., Harris, D., Liu, Z., Hazan‐Halevy, I., Wang, Y., Kantarjian, H. M., Priebe, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0593 · Cited by 128
STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Jung, J. E., Kim, H. S., Lee, C. S., Shin, Y., Kim, Y.-N., Kang, G. H., Kim, T.-Y., Juhnn, Y., Kim, S. J., Park, J., et al. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.5.479 · Cited by 128
Self-citationHaftchenary, S., Luchman, H. A., Jouk, A. O., Veloso, A. J., Page, B. D. G., Cheng, X. R., Dawson, S. S., Grinshtein, N., Shahani, V. M., Kerman, K., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4003138 · Cited by 126
Chen, H., Yang, Z., Ding, C., Chu, L., Zhang, Y., Terry, K., Liu, H., Shen, Q., & Zhou, J. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3003082 · Cited by 122
Small Molecule Inhibitors of Stat3 Signaling Pathway
Deng, J. N., Grande, F., & Neamati, N. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006922 · Cited by 121
Chen, Z., Lee, F. Y., Bhalla, K. N., & Wu, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020172 · Cited by 120
Saini, U., Naidu, S. I., ElNaggar, A. C., Bid, H. K., Wallbillich, J. J., Bixel, K. L., Bolyard, C. M., Suarez, A. A., Kaur, B., Kuppusamy, P., et al. (2016) · Oncogene · doi:10.1038/onc.2016.197 · Cited by 119
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
Li, S., Priceman, S. J., Xin, H., Zhang, W., Deng, J., Liu, Y., Huang, J., Zhu, W., Chen, M., Hu, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081657 · Cited by 117
Herbeuval, J., Lelièvre, E., Lambert, C., Dy, M., & Genin, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4630 · Cited by 115
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Plimack, E. R., LoRusso, P. M., Mccoon, P. E., Tang, W., Krebs, A. D., Curt, G. A., & Eckhardt, S. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0198 · Cited by 115
Wei, W., Tweardy, D. J., Zhang, M., Zhang, X., Landua, J. D., Petrovic, I., Bu, W., Roarty, K. P., Hilsenbeck, S. G., Rosen, J. M., et al. (2014) · Stem Cells · doi:10.1002/stem.1752 · Cited by 112
van der Zee, M., Sacchetti, A., Cansoy, M., Joosten, R., Teeuwssen, M., Heijmans‐Antonissen, C., Ewing‐Graham, P. C., Burger, C. W., Blok, L. J., & Fodde, R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2498 · Cited by 96
Chen, M., Liu, Y., Varley, P. R., Chang, Y., He, X.-X., Huang, H., Tang, D., Lotze, M. T., Lin, J., & Tsung, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2147 · Cited by 95
Buerger, C., Nagel‐Wolfrum, K., Kunz, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301629200 · Cited by 94
STAT3, but not ERKs, mediates the IL-6–induced proliferation of renal cancer cells, ACHN and 769P
Horiguchi, A., Oya, M., Marumo, K., & Murai, M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00206.x · Cited by 94
Huang, C., Cao, J., Huang, K., Zhang, F., Jiang, T., Zhu, L., & Qiu, Z. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00340.x · Cited by 94
Yan, S., Li, Z., & Thiele, C. J. (2013) · Oncotarget · doi:10.18632/oncotarget.930 · Cited by 93
Wu, L., Du, H., Li, Y., Qu, P., & Yan, C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.028 · Cited by 89
Kanai, M., Konda, Y., Nakajima, T., Izumi, Y., Kanda, N., Nanakin, A., Kubohara, Y., & Chiba, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206109 · Cited by 88
Kim, B., Yi, E. H., & Ye, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0795-8 · Cited by 87
Self-citationSTAT signaling in the pathogenesis and treatment of myeloid malignancies
Bar‐Natan, M., Nelson, E. A., Xiang, M. H., & Frank, D. A. (2012) · JAK-STAT · doi:10.4161/jkst.20006 · Cited by 85
Antonarakis, E. S., Heath, E. I., Posadas, E. M., Yu, E. Y., Harrison, M. R., Bruce, J. Y., Cho, S. Y., Wilding, G. E., Fetterly, G. J., Hangauer, D. G., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2079-z · Cited by 77
Nam, S., Wen, W. X., Schroeder, A., Herrmann, A., Yu, H., Cheng, X., Merz, K., Eisenbrand, G., Li, H., Yuan, Y., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.013 · Cited by 75
Chang, A. Y., & Wang, M. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-267 · Cited by 74
Qu, Y., Oyan, A. M., Liu, R., Hua, Y., Zhang, J., Hovland, R., Popa, M. L., Liu, X., Brokstad, K. A., Simon, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1560 · Cited by 74
Kim, K.-J., Kwon, S.-H., Yun, J.-H., Jeong, H.-S., Kim, H.-R., Lee, E. H., Ye, S.-K., & Cho, C.-H. (2017) · Oncogene · doi:10.1038/onc.2017.148 · Cited by 70
Self-citationSRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
Michels, S. Y. F., Trautmann, M., Sievers, E., Kindler, D., Huss, S., Renner, M., Friedrichs, N., Kirfel, J., Steiner, S., Endl, E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3023 · Cited by 68
Blaylock, R. L. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.157890 · Cited by 67
Sun, X., Sui, Q., Zhang, C., Tian, Z., & Zhang, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1087 · Cited by 67
A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells
Wojcik, E. J., Sharifpoor, S., Miller, N., Wright, T. G., Watering, R., Tremblay, E. A., Swan, K., Mueller, C. R., & Elliott, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1209306 · Cited by 63
Fujiwara, Y., Takeya, M., & Komohara, Y. (2014) · BioMed Research International · doi:10.1155/2014/348539 · Cited by 61
Tseng, L., Huang, P., Chen, Y.-R., Chen, Y., Chou, Y.-C., Chen, Y., Chang, Y.-L., Hsu, H., Lan, Y., Chen, K.-H., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.188730 · Cited by 60
Phase II study of the Src kinase inhibitor saracatinib (AZD0530) in metastatic melanoma
Gangadhar, T. C., Clark, J. I., Karrison, T. G., & Gajewski, T. F. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9897-4 · Cited by 58
Pancotti, F., Roncuzzi, L., Maggiolini, M., & Gasperi‐Campani, A. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.015 · Cited by 55
Antagonism of the Stat3–Stat3 Protein Dimer with Salicylic Acid Based Small Molecules
Fletcher, S., Page, B. D. G., Zhang, X., Yue, P., Li, Z. H., Sharmeen, S., Singh, J., Zhao, W. M., Schimmer, A. D., Trudel, S., et al. (2011) · ChemMedChem · doi:10.1002/cmdc.201100194 · Cited by 54
Correlation Analysis of JAK-STAT Pathway Components on Prognosis of Patients with Prostate Cancer
Liu, X., He, Z., Li, C., Huang, G., Ding, C., & Liu, H. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9410-y · Cited by 53
Emerging strategies for cancer immunoprevention
Roeser, J. C., Leach, S. D., & McAllister, F. E. (2015) · Oncogene · doi:10.1038/onc.2015.98 · Cited by 53
Sonnenblick, A., Shriki, A., Galun, E., Axelrod, J. H., Daum, H., Rottenberg, Y., Hamburger, T., Mali, B., & Peretz, T. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0789-z · Cited by 46
Kumar, A., & Bora, U. (2012) · Bioinformation · doi:10.6026/97320630008988 · Cited by 36
Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs
Kim, B., Won, C., Lee, Y.-H., Choi, J. S., Noh, K. H., Han, S., Lee, H., Lee, C. S., Lee, D., Ye, S., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.009 · Cited by 35
Self-citationLiu, L., Gaboriaud‐Kolar, N., Vougogiannopoulou, K., Tian, Y., Wu, J., Wen, W. X., Skaltsounis, A., & Jove, R. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26721 · Cited by 30
HIC1 interacts with and modulates the activity of STAT3
Lin, Y.-M., Wang, C.-M., Jeng, J., Leprince, D., & Shih, H. (2013) · Cell Cycle · doi:10.4161/cc.25365 · Cited by 24
Pollack, I. F., Premkumar, D. R., Jane, E. P., Agostino, N. R., & Scialabba, J. L. (2010) · Journal of Carcinogenesis · doi:10.4103/1477-3163.65448 · Cited by 24
Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells
Seltana, A., Guezguez, A., Lepage, M., Basora, N., & Beaulieu, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.085 · Cited by 20
Ge, H., Liu, H.-G., Fu, Z., & Sun, Z. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000207 · Cited by 14
Cited by
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578
The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Huang, B., Lang, X., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023177 · Cited by 479
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Zolfaghari Emameh, R., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2022) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 397
Advancements in nanoparticle-based treatment approaches for skin cancer therapy
Zeng, L., Gowda, B. H. J., Ahmed, M. G., Abourehab, M. A. S., Chen, Z.-S., Zhang, C., Li, J., & Kesharwani, P. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01708-4 · Cited by 365
Tumor cell plasticity in targeted therapy-induced resistance: Mechanisms and new strategies
Shi, Z.-D., Pang, K., Wu, Z.-X., Dong, Y., Hao, L., Qin, J.-X., Wang, W., Chen, Z.-S., & Han, C.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01383-x · Cited by 256
Metadata
- Authors
- Lee, H., Jeong, A. J., & Ye, S.-K.
- Venue
- BMB Reports
- Published
- 2019-07-31
- Volume
- 52
- Issue
- 7
- Pages
- 415-423
- ISSN
- 1976-6696 (ISSN-L)
- 1976-670X
- OpenAlex
- W2965118073
- Cited by
- 295
- References
- 108
- FWCI
- 12.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.